載入...
Endocannabinoids and the gastrointestinal tract: what are the key questions?
Cannabinoid (CB(1)) receptor activation acts neuronally, reducing GI motility, diarrhoea, pain, transient lower oesophageal sphincter relaxations (TLESRs) and emesis, and promoting eating. CB(2) receptor activation acts mostly via immune cells to reduce inflammation. What are the key questions which...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2190011/ https://ncbi.nlm.nih.gov/pubmed/17767170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707422 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|